DJIA 16,356.99 5.61 0.03%
NASDAQ 4,738.56 -11.42 -0.24%
S&P 500 1,946.37 -2.49 -0.13%
market minute promo

NxStage Medical (NASDAQ: NXTM)

16.46 -0.49 (-2.89%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NXTM $16.46 -2.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.98
Previous Close $16.95
Daily Range $16.34 - $17.10
52-Week Range $11.50 - $19.63
Market Cap $1.0B
P/E Ratio -47.08
Dividend (Yield) $0.00 (0.0%)
Volume 581,495
Average Daily Volume 644,960
Current FY EPS -$0.31

Sector

Healthcare

Industry

Healthcare IT

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website: http://www.nxstage.com/

News & Commentary

NxStage Medical Keeps Growing, Sees Even Better Times Ahead

The dialysis-services company saw solid revenue growth and raised its guidance for the full 2015 year.

Notable Two Hundred Day Moving Average Cross - NXTM

Insider Trading Alert - PPBI, DXPE And NXTM Traded By Insiders

NXTM January 2016 Options Begin Trading

Nxstage (NXTM) Shares March Higher, Can It Continue?

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2015 Results - Earnings Call Transcript

Nxstage Medical Soars Following Better-Than-Expected Q2 Results

2:30pm ET: Nxstage Medical stock rises as much as 13% out of the gate following market-topping Q2 results, but has since settled into gains of around 7%.

NxStage Medical (NXTM) Q2 2015 Results - Earnings Call Webcast

Structurally Light On Growth, Baxter Has A Lot Of Work Ahead

Point 72 Takes A 5% Stake In NxStage Medical

See More NXTM News...

NXTM's Top Competitors

NXTM $16.46 (-2.89%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $69.89 (-2.32%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV